Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.52 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.52 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.52 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | PTPRC | P08575 | 1/20 | 0.45 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.45 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30427138 | 0.89 | MAPT (0.56) | MAPTKDM4EGAACYP19A1CYP11B1 | |
| SCHEMBL2210399 | 0.89 | MAPT (0.56) | MAPTKDM4EGAACYP19A1CYP11B1 | |
| SCHEMBL3790341 | 0.88 | MAPT (0.51) | MAPTKDM4EGAACYP19A1CYP11B1 | |
| SCHEMBL27902946 | 0.87 | TP53 (0.54) | MAPTKDM4EGAACYP19A1CYP11B1 | |
| SCHEMBL3789504 | 0.86 | PTGDR2 (0.65) | MAPTKDM4EGAAPTGDR2ALDH1A1 | |
| SCHEMBL347279 | 0.85 | MAPT (0.63) | MAPTKDM4EGAACYP19A1CYP11B1 | |
| SCHEMBL8897316 | 0.83 | CYP11B1 (0.56) | KDM4ECYP19A1CYP11B1CYP11B2PTGDR2 | |
| SCHEMBL27324840 | 0.82 | EGFR (0.56) | MAPTKDM4EALDH1A1PTPRCMAPK1 | |
| SCHEMBL27920645 | 0.82 | ALDH1A1 (0.61) | MAPTKDM4EGAACYP19A1CYP11B1 | |
| SCHEMBL3791209 | 0.81 | CYP19A1 (0.74) | MAPTGAACYP19A1CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103097353-B | Immunomodulator and anti-inflammatory compound | INCOZEN THERAPEUTICS PVT LTD | 2015-03-04 | — | — | CN | disclosed |
| CN-103097353-A | Novel immunomodulator and anti-inflammatory compounds | INCOZEN THERAPEUTICS PVT LTD | 2013-05-08 | — | — | CN | disclosed |
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | MAPT 3312/4885KDM4E 2606/4885GAA 1755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.